Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

564
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
564
Neuroplasticity01:01

Neuroplasticity

338
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
338
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

Molecular basis and cellular effects of Janus-class-driven cytoplasmic PYK2 coacervates.

Communications biology·2026
Same author

Deep Learning-Based Mpox Skin Lesion Detection and Real-Time Monitoring in a Smart Healthcare System.

Diagnostics (Basel, Switzerland)·2025
Same author

Phased genome assemblies and pangenome graphs of human populations of Japan and Saudi Arabia.

Scientific data·2025
Same author

A reference quality, fully annotated diploid genome from a Saudi individual.

Scientific data·2024

Related Experiment Video

Updated: Jun 27, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K

Prioritizing genomic variants through neuro-symbolic, knowledge-enhanced learning.

Azza Althagafi1,2,3, Fernando Zhapa-Camacho1,2, Robert Hoehndorf1,2,4

  • 1Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), 4700 KAUST, Thuwal 23955, Saudi Arabia.

Bioinformatics (Oxford, England)
|May 2, 2024
PubMed
Summary

A new computational method, EmbedPVP, prioritizes genetic variants for rare disease diagnosis by integrating genomic data with clinical phenotypes. This approach enhances diagnostic capabilities beyond current limitations, aiding in identifying novel disease-causing variants.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.0K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K

Related Experiment Videos

Last Updated: Jun 27, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.0K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K

Area of Science:

  • Genomics
  • Computational Biology
  • Medical Genetics

Background:

  • Whole-exome and genome sequencing are crucial for rare disease diagnosis but often leave patients undiagnosed.
  • Interpreting genomic variants requires understanding gene function, expression, and physiological impacts.
  • Existing phenotype-based methods are limited by reliance on known gene-phenotype associations and inconsistent phenotype data.

Purpose of the Study:

  • To develop a novel computational method for prioritizing variants implicated in genetic diseases.
  • To overcome limitations of current phenotype-based approaches by integrating broader biological knowledge.
  • To improve the diagnostic yield of genomic sequencing in rare disease patients.

Main Methods:

  • Developed Embedding-based Phenotype Variant Predictor (EmbedPVP), a computational tool.
  • Integrated genomic information with clinical phenotypes using neuro-symbolic, knowledge-enhanced machine learning.
  • Leveraged background knowledge from human and model organisms regarding molecular mechanisms of abnormal phenotypes.

Main Results:

  • EmbedPVP effectively prioritizes variants involved in genetic diseases.
  • The method successfully combines genomic data and clinical phenotypes.
  • Demonstrated efficacy on synthetic and real-world genomic datasets.

Conclusions:

  • EmbedPVP offers a powerful new approach for variant prioritization in rare disease diagnosis.
  • The method enhances the interpretation of genomic data by incorporating extensive biological knowledge.
  • EmbedPVP has the potential to increase diagnostic rates for previously undiagnosed rare disease patients.